Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.
Walsh
T J
TJ
Infectious Diseases Section, National Cancer Institute, Bethesda, Maryland 20892.
Pizzo
P A
PA
D000818:Animals; D002176:Candida albicans / Q000254:growth & development / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology*; D003561:Cytarabine / Q000008:administration & dosage; D004195:Disease Models, Animal; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000382:microbiology*; D005839:Gentamicins / Q000494:pharmacology; D016867:Immunocompromised Host; D007413:Intestinal Mucosa / Q000187:drug effects / Q000382:microbiology; D008775:Methylprednisolone / Q000494:pharmacology; D011817:Rabbits; D014640:Vancomycin / Q000494:pharmacology
D005839:Gentamicins; D003561:Cytarabine; D014640:Vancomycin; D008775:Methylprednisolone